Airway cancer is among the most common neoplasia today, especially lung
cancer, considered the leading cause of cancer death among men and women
worldwide. In late 2019, in Wuhan, China, the SARS-CoV-2 virus emerged, the virus
that causes COVID-19. This pathogen can affect individuals of all age groups, with a
greater propensity to infect people with risk factors. The impact of the COVID-19
pandemic on oncology clinical practice culminated in the delay in the management of
patients with different types of cancer, including lung cancer. The objective of this study
was to characterize the epidemiological profile and analyze the number of diagnoses,
hospitalizations and deaths of patients with lung cancer, bronchi and trachea in
different federative units of Brazil. The population studied in this work consists of a
sample of the Brazilian population with data taken from a public database available at
DATASUS. This sample was divided into the period from March 2018 to November
2019 (pre-COVID19 period) and March 2020 to November 2022 (COVID-19 period).
The differences between the Brazilian federative units were analyzed, in relation to the
distribution according to sex, according to the number of hospitalizations and the
number of deaths from lung cancer before and during the Covid-19 pandemic. The
sample consisted of 42,583 individuals diagnosed with malignant neoplasm of the
bronchi and lungs. During the pre-pandemic period, 24,228 diagnoses of lung cancer
were made, while during the pandemic there were 18,355 cases of the disease. In
conclusion, there was no increase in the number of diagnoses, hospitalizations and
deaths in the period described and males were the most affected, corroborating the
data in the literature.
|
